O'Rourke & Company’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $823K | Sell |
6,509
-216
| -3% | -$27.3K | 0.38% | 64 |
|
|
2025
Q1 | $860K | Buy |
6,725
+2
| +0% | +$256 | 0.43% | 55 |
|
|
2024
Q4 | $889K | Sell |
6,723
-136
| -2% | -$18K | 0.44% | 52 |
|
|
2024
Q3 | $999K | Buy |
6,859
+234
| +4% | +$34.1K | 0.5% | 44 |
|
|
2024
Q2 | $909K | Hold |
6,625
| – | – | 0.51% | 43 |
|
|
2024
Q1 | $909K | Sell |
6,625
-142
| -2% | -$19.5K | 0.53% | 42 |
|
|
2023
Q4 | $919K | Buy |
6,767
+200
| +3% | +$27.2K | 0.59% | 40 |
|
|
2023
Q3 | $803K | Sell |
6,567
-114
| -2% | -$13.9K | 0.59% | 41 |
|
|
2023
Q2 | $848K | Sell |
6,681
-150
| -2% | -$19K | 0.59% | 37 |
|
|
2023
Q1 | $882K | Buy |
6,831
+70
| +1% | +$9.04K | 0.67% | 36 |
|
|
2022
Q4 | $888K | Buy |
6,761
+2
| +0% | +$263 | 0.7% | 36 |
|
|
2022
Q3 | $791K | Sell |
6,759
-197
| -3% | -$23.1K | 0.69% | 36 |
|
|
2022
Q2 | $818K | Sell |
6,956
-742
| -10% | -$87.3K | 0.69% | 38 |
|
|
2022
Q1 | $1M | Sell |
7,698
-1,004
| -12% | -$131K | 0.69% | 38 |
|
|
2021
Q4 | $1.33M | Buy |
+8,702
| New | +$1.33M | 0.89% | 25 |
|